HopES Sarcoma Trial
What is Sarcoma Cancer?
Common Signs and Symptoms
Pain off and on in the affected area, which may be worse at night
Swelling, which may start weeks after the pain
A limp (if sarcoma is in leg)
What Are Clinical Trials?
Clinical trials are research studies that investigate new treatments or new combinations of treatments. Sarcoma clinical trials are necessary to determine whether new treatments developed in the laboratory are beneficial to people living with Ewing’s and sarcomas cancers. The Food and Drug Administration (FDA) reviews and analyzes data from successful clinical trials to determine whether an experimental treatment should be approved for a specific disease or disorder.
Will I Benefit From Participating?
The study medicine is an investigational cancer metabolism-based compound and you may or may not achieve a clinical benefit. By participating in the HopES Sarcoma Study, you may:
- Take an active role in your own healthcare
- Contribute to medical research and helping to shape the future of medicine
About HopES Sarcoma Trial
About TYME SM-88
About the Joseph Ahmed Foundation
Clinical Trial Frequently Asked Questions
An investigational medication has been tested in the laboratory and the U.S. Food and Drug Administration (FDA) is allowing it to be tested in people. It is not approved for sale by the FDA or other government agencies. A clinical trial tests how well an investigational medication works and whether it is safe to use for a specific disease or disorder.
A clinical trial has a structured set of clinic visits, tests, and drug dosing schedule the patient must follow. Information about how you feel and how you are reacting to the study treatment is collected.
Protecting the health and safety of people who take part in clinical trials is the highest priority for clinical researchers throughout the entire study process. All clinical trials follow strict federal guidelines on how volunteers must be treated.
As a result of today’s challenges with COVID-19, and based on the Principal Investigators guidance, eligible patients may be able to take oral SM-88 at home as well as interact with the clinical trial physician through telemedicine remotely. This way we keep all participants in the TYME-88-Panc trial compliant and safe when it comes to COVID-19 guidelines and best practices.
You have the right to leave a clinical trial at any time, for any reason. If you decide to leave a trial, talk to your doctor first. You will want to know how leaving the trial might affect your health and what other treatment options may be available.
More information on this clinical trial can be found on clinicaltrials.gov